SynAct Pharma AB (publ) (STO:SYNACT)
13.00
-0.12 (-0.91%)
Nov 20, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 727.98 million as of November 20, 2026. It is the 26,974th most valuable company in the world and the 339th biggest in Sweden. Its market cap has decreased by 34.53% in one year.
Market Cap
727.98M
Enterprise Value
731.14M
Revenue
n/a
Global Rank
Country Rank
#339 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 727.98M, an increase of 1,041.89%. That is a compound annual growth rate of 26.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 727.98M | -39.60% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.54B |
| Flerie AB | 1.10B |
| Infant Bacterial Therapeutics AB | 956.47M |
| AlzeCure Pharma AB | 805.32M |
| Medivir AB | 701.58M |
| Oncopeptides AB | 668.43M |
| Xspray Pharma AB | 496.93M |
| FluoGuide | 482.30M |